Rare case of stage IA epithelial ovarian cancer with bone as the first site of recurrent metastasis.
Ovarian cancer is one of the main gynecological malignancies including cervical cancer and endometrial cancer. Epithelial ovarian cancer generally presents with already advanced disease at the time of diagnosis and is accompanied by poor prognosis. However, stage I ovarian cancer defined as lesions confined to the ovary is usually considered to have a good prognosis, illustrated by a 5-year survival rate of greater than 70-80%. Also, recurrences tend to be late and are usually in the abdominopelvic cavity. Metastases to the skeletal structures are rare. We report a rare case of early stage IA ovarian cancer, in which the first recurrent lesion was bone metastasis.
Chang
K-H
KH
Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
Lee
J-P
JP
Ryu
H-S
HS
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy; D002945:Cisplatin / Q000627:therapeutic use; D018282:Cystadenocarcinoma, Mucinous / Q000556:secondary* / Q000628:therapy; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000628:therapy; D017239:Paclitaxel / Q000627:therapeutic use
D000970:Antineoplastic Agents; D017239:Paclitaxel; D002945:Cisplatin